Keywords: Genzyme, Consent decree, FDA, Correct manufacturing violations, Fine

Genzyme signs consent decree with US FDA to correct violations at manufacturing plant and give up $175 million in profits

Article | 25 May 2010

Troubled US biotechnology firm Genzyme has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Massachusetts, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Cerezyme

Fabrazyme

Thyrogen

Go to drug listing